Dear Bull, The FDA has scheduled a Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting on Jan. 26 “to discuss the future vaccination regimens addressing COVID-19.” The vague description regarding the nature of the upcoming VRBPAC meeting lacks transparency. Regardless of their agenda, we must demand that VRBPAC looks at the data regarding the failure of the COVID-19 vaccine program. |